Clinical trial Recruiting at 1 site Observational Ages 50 to 80

Impact of degenerative spondylolisthesis on outcomes of endoscopic surgery for spinal stenosis

Official title: Effect of Degenerative Spondylolisthesis on the Clinical Outcome of Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis: a Single-center, Prospective Cohort Trial Protocol

Run by Beijing Friendship Hospital · NCT06394089 · Data updated 2026-11-12

This study is testing how degenerative spondylolisthesis affects recovery after endoscopic surgery for lumbar spinal stenosis in patients aged 50-80 who haven't found relief from other treatments.

More Lumbar Spinal Stenosis trials

Quick facts

Study typeObservational
Ages50 Years to 80 Years
SexAll
Enrollment150 (estimated)
SponsorBeijing Friendship Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedFebruary 28, 2027
Study endsFebruary 28, 2027
Registry record updatedJune 6, 2025
Trial IDNCT06394089 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 50-80 with lumbar spinal stenosis and degenerative spondylolisthesis of less than grade II who have not benefited from conservative treatment.

Probably not a fit

Patients with isthmic lumbar spondylolisthesis, grade II or higher degenerative spondylolisthesis, or other significant spinal conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate how degenerative spondylolisthesis affects the clinical outcomes of unilateral biportal endoscopy in patients with lumbar spinal stenosis. It will involve a single-center, prospective cohort design, focusing on patients aged 50-80 who have been diagnosed with lumbar spinal stenosis affecting 1-2 vertebral levels and have not responded to conservative treatment. The study will assess the effectiveness of the surgical intervention in this specific patient population, providing valuable insights into their recovery and overall outcomes.

Why it matters

Potential benefit: If successful, this study could enhance surgical decision-making and improve recovery outcomes for patients with lumbar spinal stenosis and degenerative spondylolisthesis.

How similar studies have gone: While similar studies have explored outcomes of endoscopic surgery for spinal stenosis, this specific focus on degenerative spondylolisthesis is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age range: 50-80 years
* Diagnosis of LSS affecting 1-2 vertebral levels
* Predominant manifestation of neurogenic intermittent claudication, with ineffective conservative treatment for at least 3 months
* Presence of lumbar DS of less than grade II and absence of spine instability
* Willingness to participate in the study and complete follow-up assessments.

Exclusion Criteria:

* Diagnosis of isthmic lumbar spondylolisthesis or lumbar DS of grade ≥II
* Evidence of instability at the affected vertebral level (intervertebral angle change \> 15° and/or vertebral translation ≥ 4.5 mm in standing flexion-extension radiographs of the lumbar spine)
* History of prior surgery at the affected vertebral level
* Presence of scoliosis with a Cobb angle \>20º
* Presence of other conditions affecting the lumbar spine (infection, tumor, fracture, neurological diseases, and others)
* Medical disorders that preclude surgical tolerance
* Participation in other clinical research projects related to the treatment of lumbar spinal stenosis.

Where it's running

  • Beijing Friendship Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.